Gilead Sciences
GILD
#80
Rank
S$270.41 B
Marketcap
S$218.02
Share price
-0.75%
Change (1 day)
31.76%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): S-$4.08

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S-$4.00. In 2025 the company made an earnings per share (EPS) of S$8.84 an increase over its 2024 EPS that were of S$0.49.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.08-146.14%
2025S$8.841702.63%
2024S$0.49-91.65%
2023S$5.8723.98%
2022S$4.73-25.86%
2021S$6.394850%
2020S$0.13-97.64%
2019S$5.470.9%
2018S$5.4218.71%
2017S$4.57-64.88%
2016S$13.01-18.45%
2015S$15.9555.28%
2014S$10.27296.02%
2013S$2.5917.89%
2012S$2.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-315.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.92-122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.55-288.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.86-1,096.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.42-660.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$3.04-176.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.60-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$20.22-605.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-132.03%๐Ÿ‡บ๐Ÿ‡ธ USA